Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model. [electronic resource]
Producer: 20210204Description: 185-194 p. digitalISSN:- 1872-8332
- Antineoplastic Combined Chemotherapy Protocols -- economics
- Biomarkers, Tumor -- metabolism
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cost-Benefit Analysis
- Follow-Up Studies
- Health Care Costs
- Humans
- Lung Neoplasms -- drug therapy
- Models, Statistical
- Prognosis
- Retrospective Studies
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.